Chemotherapy activates cancer-associated fibroblasts to maintain colorectal cancer-initiating cells by IL-17A

Chemotherapy stimulates cancer-associated fibroblasts to secrete interleukin-17A to provide maintenance cues to support the growth of colorectal cancer-initiating cells.

• Publication year

  2013

• Venue

  Journal of Experimental Medicine

• Publication date

  2013-12-16

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1084/jem.20131195PMID 24323355PMCID 3865474
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differential expression of CD133 based on microsatellite instability status in human colorectal cancer

  2014cited by this paper
• Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis

  2014cited by this paper
• Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties.

  2013cited by this paper
• Changes in the Secretory Profile of NSCLC-Associated Fibroblasts after Ablative Radiotherapy: Potential Impact on Angiogenesis and Tumor Growth.

  2013cited by this paper
• CD66c is a novel marker for colorectal cancer stem cell isolation, and its silencing halts tumor growth in vivo

  2013cited by this paper
• Tracing the cellular origin of cancer

  2013cited by this paper
• Plasticity of tumour and immune cells: a source of heterogeneity and a cause for therapy resistance?

  2013cited by this paper
• An interleukin-17–mediated paracrine network promotes tumor resistance to anti-angiogenic therapy

  2013cited by this paper
• Endothelial cells promote the colorectal cancer stem cell phenotype through a soluble form of Jagged-1.

  2013cited by this paper
• A colorectal cancer classification system that associates cellular phenotype and responses to therapy

  2013cited by this paper
• Dependency of colorectal cancer on a TGF-β-driven program in stromal cells for metastasis initiation.

  2012influential reference
• Adult mammalian stem cells: the role of Wnt, Lgr5 and R‐spondins

  2012cited by this paper
• How many molecular subtypes? Implications of the unique tumor principle in personalized medicine

  2012cited by this paper
• Induction of the stem-like cell regulator CD44 by Rho kinase inhibition contributes to the maintenance of colon cancer-initiating cells.

  2012influential reference
• Faculty Opinions recommendation of Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion.

  2012cited by this paper
• Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth

  2012cited by this paper
• Slug and Sox9 cooperatively determine the mammary stem cell state.

  2012cited by this paper
• Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis.

  2012cited by this paper
• Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth

  2012cited by this paper
• Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis.

  2012cited by this paper
• Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistance.

  2012cited by this paper
• Tumor microenvironment induces innate RAF-inhibitor resistance through HGF secretion

  2012cited by this paper
• Cancer stem cells: impact, heterogeneity, and uncertainty.

  2012cited by this paper
• A CXCL1 paracrine network links cancer chemoresistance and metastasis.

  2012cited by this paper
• Cancer-stimulated mesenchymal stem cells create a carcinoma stem cell niche via prostaglandin E2 signaling.

  2012cited by this paper
• Cyclin-dependent kinase 8 mediates chemotherapy-induced tumor-promoting paracrine activities

  2012cited by this paper
• Role of IL-17A in the development of colitis-associated cancer.

  2011cited by this paper
• Significance of Lgr5+ve Cancer Stem Cells in the Colon and Rectum

  2011cited by this paper
• Chemotherapeutic resistance: surviving stressful situations.

  2011cited by this paper
• Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer.

  2011cited by this paper
• Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts

  2011influential reference
• Bone marrow stromal cells protect myeloma cells from bortezomib induced apoptosis by suppressing microRNA-15a expression

  2011cited by this paper
• Microenvironmental regulation of stem cells in intestinal homeostasis and cancer

  2011cited by this paper
• Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks.

  2011cited by this paper
• Targeted treatments in colorectal cancer: state of the art and future perspectives

  2010cited by this paper
• Cancer associated fibroblasts (CAFs) in tumor microenvironment.

  2010cited by this paper
• Wnt activity defines colon cancer stem cells and is regulated by the microenvironment

  2010influential reference
• The Stem Cell Marker CD133 Associates with Enhanced Colony Formation and Cell Motility in Colorectal Cancer

  2010influential reference
• Stromal Fibroblasts in Digestive Cancer

  2010influential reference
• Molecular biology of cancer-associated fibroblasts: can these cells be targeted in anti-cancer therapy?

  2010influential reference
• DNA damage-mediated induction of a chemoresistant niche.

  2010cited by this paper
• Expansion of CD133+ colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery

  2010influential reference
• Cancer stem cells from colorectal cancer-derived cell lines

  2010influential reference
• Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent Manner.

  2010cited by this paper
• Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis

  2010cited by this paper
• Vascular endothelial growth factor and epidermal growth factor signaling pathways as therapeutic targets for colorectal cancer.

  2010cited by this paper
• Distinct Expression Levels and Patterns of Stem Cell Marker, Aldehyde Dehydrogenase Isoform 1 (ALDH1), in Human Epithelial Cancers

  2010influential reference
• Targeting Interleukin 6 Signaling Suppresses Glioma Stem Cell Survival and Tumor Growth

  2009cited by this paper
• A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses

  2009influential reference
• Transcriptional control of the inflammatory response

  2009cited by this paper
• Molecular origins of cancer: Molecular basis of colorectal cancer.

  2009cited by this paper
• TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma.

  2009cited by this paper
• Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis.

  2009cited by this paper
• Protocol for the Examination of Specimens from Patients with Primary Carcinoma of the Colon and Rectum Well-differentiated neuroendocrine neoplasms

  2009cited by this paper
• Genetic and epigenetic classifications define clinical phenotypes and determine patient outcomes in colorectal cancer

  2009cited by this paper
• Prognostic Significance of the Cancer Stem Cell Markers CD133, CD44, and CD166 in Colorectal Cancer

  2009cited by this paper
• Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition.

  2009cited by this paper
• PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment.

  2009cited by this paper
• Crypt stem cells as the cells-of-origin of intestinal cancer

  2009cited by this paper
• Colon cancer stem cells

  2009cited by this paper
• ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays.

  2009influential reference
• Protocol for the examination of specimens from patients with primary carcinoma of the colon and rectum.

  2009cited by this paper
• Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents.

  2008cited by this paper
• Induction of cancer metastasis by cyclophosphamide pretreatment of host mice: an opposite effect of chemotherapy.

  2008cited by this paper
• Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity

  2008influential reference
• Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following Chemotherapy

  2008cited by this paper
• CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors.

  2008cited by this paper
• CD44 is of Functional Importance for Colorectal Cancer Stem Cells

  2008influential reference
• Molecular origins of cancer.

  2008cited by this paper
• Cancer as an overhealing wound: an old hypothesis revisited

  2008cited by this paper
• 17-Allylamino-17-demethoxygeldanamycin enhances the lethality of deoxycholic acid in primary rodent hepatocytes and established cell lines

  2007cited by this paper
• Colon cancer stem cells

  2007cited by this paper
• Heterogeneity of stromal fibroblasts in tumors.

  2007cited by this paper
• Heterogeneity of stromal fibroblasts in tumor

  2007cited by this paper
• Identification and expansion of human colon-cancer-initiating cells

  2007cited by this paper
• Phenotypic characterization of human colorectal cancer stem cells

  2007influential reference
• Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4.

  2007cited by this paper
• Identification of stem cells in small intestine and colon by marker gene Lgr5

  2007cited by this paper
• A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

  2007influential reference
• Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

  2006cited by this paper
• [Breast cancer].

  2006cited by this paper
• Therapy-Induced Acute Recruitment of Circulating Endothelial Progenitor Cells to Tumors

  2006cited by this paper
• Identification of fibroblast heterogeneity in the tumor microenvironment

  2006influential reference
• CD44 promotes resistance to apoptosis in murine colonic epithelium

  2005cited by this paper
• American Cancer Society

  2005cited by this paper
• Suppression of tumor development and metastasis formation in mice lacking the S100A4(mts1) gene.

  2005cited by this paper
• Supplemental Data Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion

  2005cited by this paper
• Expression of the carcinoembryonic antigen gene is inhibited by SOX9 in human colon carcinoma cells.

  2005cited by this paper
• Context, tissue plasticity, and cancer: are tumor stem cells also regulated by the microenvironment?

  2005cited by this paper
• Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anti-cancer therapy?

  2004cited by this paper
• CD44 promotes resistance to apoptosis in human colon cancer cells.

  2004cited by this paper
• The stroma reaction myofibroblast: a key player in the control of tumor cell behavior.

  2004cited by this paper
• Molecular characterization of the tumor microenvironment in breast cancer.

  2004cited by this paper
• SOX9 is an intestine crypt transcription factor, is regulated by the Wnt pathway, and represses the CDX2 and MUC2 genes

  2004cited by this paper
• Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia

  2003cited by this paper
• Tumours : wounds that do not heal.

  2002cited by this paper
• beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium.

  2002cited by this paper
• α Smooth muscle actin positive stromal cells in gastric carcinoma

  2002cited by this paper
• Role of Myofibroblasts at the Invasion Front

  2002cited by this paper
• Inhibition of transforming growth factor-beta activity decreases angiogenesis in a human prostate cancer-reactive stroma xenograft model.

  2002cited by this paper

• Advancements in cancer stem cell therapy: The effective integration of traditional Chinese medicine and nanotechnology.

  2026cites this paper
• Transforming Role of Cancer Associated Fibroblasts: From Therapeutic Barriers to Promising Targets.

  2026cites this paper
• LOXL2⁺ cancer-associated fibroblasts shape WNT signaling to drive chemoresistance and poor outcomes in colorectal cancer: Insights from multi-omics and epidemiological analyses

  2026cites this paper
• Validation of chemoresistance phenotypes in pleural mesothelioma across 2D, 3D, and in vivo models.

  2026cites this paper
• Targeting cytokine and chemokine signaling pathways for enhancing chemo-sensitivity in colorectal cancer

  2025cites this paper
• Comparative analysis of 3D-culture techniques for multicellular colorectal tumour spheroids and development of a novel SW48 3D-model

  2025cites this paper
• Overcoming cancer therapy resistance: From drug innovation to therapeutics.

  2025cites this paper
• Cancer-associated fibroblast-derived GAS6 increases resistance to chemotherapy through AXL/STAT3/ABCG1 in gastric cancer

  2025cites this paper
• Reporter-based screening identifies RAS-RAF mutations as drivers of resistance to active-state RAS inhibitors in colorectal cancer.

  2025cites this paper
• KRAS regulates IL-17 signal activity by affect the metastasis of osteosarcoma via an IL-17A-dependent manner

  2025cites this paper
• The multifaceted contributions of cancer-associated fibroblasts to drug resistance in primary and metastatic tumors.

  2025cites this paper
• Current perspectives and trends in colorectal cancer and cancer-associated fibroblasts: a review and bibliometric analysis

  2025cites this paper
• Construction of a risk score based on the histopathological tumour microenvironment and its prognostic value in primary operable colorectal cancer.

  2025cites this paper
• Desmoplastic reaction in the microenvironment of head and neck and other solid tumors: the therapeutic barrier

  2025cites this paper
• Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition

  2025cites this paper
• Cancer Associated Fibroblasts-derived Lactate Induces Oxaliplatin Treatment Resistance by Promoting Cancer Stemness via ANTXR1 Lactylation in Colorectal Cancer.

  2025cites this paper
• The Pro‐Migratory and Pro‐Invasive Roles of Cancer‐Associated Fibroblasts Secreted IL‐17A in Prostate Cancer

  2025cites this paper
• Alpha-linolenic acid reverses colorectal cancer drug resistance by suppressing secreted phosphoprotein 1 expression and tumor stemness.

  2025cites this paper
• Comprehensive genomic and transcriptomic analyses reveal prognostic stratification for esophageal squamous cell carcinoma

  2025cites this paper
• An α-specific PI3K inhibitor improves chemotherapy efficacy by inhibiting hepatic stellate cell activation in liver cancer.

  2025cites this paper
• Role of autophagy in cancer-associated fibroblast activation, signaling and metabolic reprograming

  2024cites this paper
• Fibroblasts in Orchestrating Colorectal Tumorigenesis and Progression

  2024cites this paper
• Interleukin-6 and Lymphocyte-to-Monocyte Ratio Indices Identify Patients with Intrahepatic Cholangiocarcinoma

  2024cites this paper
• Intestinal stem cells in intestinal homeostasis and colorectal tumorigenesis

  2024cites this paper
• Residual ANTXR1+ myofibroblasts after chemotherapy inhibit anti-tumor immunity via YAP1 signaling pathway

  2024cites this paper
• Cancer associated fibroblasts mitigate the efficacy of the combination of chemotherapy and BCL-xL targeting in triple negative breast cancer cells

  2024cites this paper
• Colorectal Cancer Stem Cell Subtypes Orchestrate Distinct Tumor Microenvironments

  2024cites this paper
• Unraveling the role of cancer-associated fibroblasts in colorectal cancer

  2024cites this paper
• Act1 drives chemoresistance via regulation of antioxidant RNA metabolism and redox homeostasis

  2024cites this paper
• TSPAN8+ myofibroblastic cancer–associated fibroblasts promote chemoresistance in patients with breast cancer

  2024cites this paper
• Low BCL-xL expression in triple-negative breast cancer cells favors chemotherapy efficacy, and this effect is limited by cancer-associated fibroblasts

  2024cites this paper
• Generation of Cancer Stem Cells by Co-Culture Methods.

  2024cites this paper
• Deciphering treatment resistance in metastatic colorectal cancer: roles of drug transports, EGFR mutations, and HGF/c-MET signaling

  2024cites this paper
• Advancements in 3D In Vitro Models for Colorectal Cancer

  2024cites this paper
• Single-cell and bulk RNA-sequence identified fibroblasts signature and CD8 + T-cell - fibroblast subtype predicting prognosis and immune therapeutic response of bladder cancer, based on machine learning: bioinformatics multi-omics study

  2024cites this paper
• Integration of bulk RNA-seq and single-cell RNA-seq constructs: a cancer-associated fibroblasts-related signature to predict prognosis and therapeutic response in clear cell renal cell carcinoma.

  2024cites this paper
• Unlocking the Potential of Therapy-Induced Cytokine Responses: Illuminating New Pathways in Cancer Precision Medicine

  2024cites this paper
• WGCNA reveals a biomarker for cancer-associated fibroblasts to predict prognosis in cervical cancer

  2024cites this paper
• Tumor cell stemness in gastrointestinal cancer: regulation and targeted therapy

  2024cites this paper
• Fibrosis‐Encapsulated Tumoroid, A Solid Cancer Assembloid Model for Cancer Research and Drug Screening

  2024cites this paper
• The prognostic model and immune landscape based on cancer-associated fibroblast features for patients with locally advanced rectal cancer

  2024cites this paper
• An exosomal strategy for targeting cancer-associated fibroblasts mediated tumors desmoplastic microenvironments

  2024cites this paper
• Comparative transcriptome of normal and cancer-associated fibroblasts

  2024cites this paper
• Cancer-associated fibroblast cell surface markers as potential biomarkers or therapeutic targets in lung cancer

  2024cites this paper
• Immune Escape Strategies in Head and Neck Cancer: Evade, Resist, Inhibit, Recruit

  2024cites this paper
• Re-Sensitizing Cancer Stem Cells to Conventional Chemotherapy Agents

  2023cites this paper
• Peptide-Platinum(IV) Conjugation Minimizes the Negative Impact of Current Anticancer Chemotherapy on Nonmalignant Cells.

  2023cites this paper
• Mechanobiology of cancer cell responsiveness to chemotherapy and immunotherapy: mechanistic insights and biomaterial platforms.

  2023cites this paper
• An Information Fusion System-Driven Deep Neural Networks With Application to Cancer Mortality Risk Estimate

  2023cites this paper
• Intimate communications within the tumor microenvironment: stromal factors function as an orchestra

  2023cites this paper
• Molecular mechanisms in colitis-associated colorectal cancer

  2023cites this paper
• Low-dose metronomic cisplatin as an antiangiogenic and anti-inflammatory strategy for cancer

  2023cites this paper
• Cancer-associated fibroblasts induce sorafenib resistance of hepatocellular carcinoma cells through CXCL12/FOLR1

  2023cites this paper
• The IL-17 family in diseases: from bench to bedside

  2023cites this paper
• Cancer-Associated Fibroblasts: Heterogeneity and Bimodality in Oncogenesis

  2023cites this paper
• Cancer-associated Fibroblasts in Neoadjuvant Setting for Solid Cancers.

  2023cites this paper
• Pericentromeric satellite lncRNAs are induced in cancer-associated fibroblasts and regulate their functions in lung tumorigenesis

  2023cites this paper
• Integrated analysis of genome-wide DNA methylation and cancer-associated fibroblasts identified prognostic biomarkers and immune checkpoint blockade in lower grade gliomas

  2023cites this paper
• Energy Metabolism, Metabolite, and Inflammatory Profiles in Human Ex Vivo Adipose Tissue Are Influenced by Obesity Status, Metabolic Dysfunction, and Treatment Regimes in Patients with Oesophageal Adenocarcinoma

  2023cites this paper
• Tumor microenvironment of cancer stem cells: Perspectives on cancer stem cell targeting

  2023cites this paper
• A potential novel biomarker: comprehensive analysis of prognostic value and immune implication of CES3 in colonic adenocarcinoma

  2023cites this paper
• Downregulation of ITGβ3 in colon adenocarcinoma reveals poor prognosis by affecting genome stability, cell cycle, and the tumor immune microenvironment

  2023cites this paper
• The Origin, Differentiation, and Functions of Cancer-Associated Fibroblasts in Gastrointestinal Cancer

  2023cites this paper
• Tumor Microenvironment Remodeling in Gastrointestinal Cancer: Role of miRNAs as Biomarkers of Tumor Invasion

  2023cites this paper
• Potential mechanisms of cancer-associated fibroblasts in therapeutic resistance.

  2023cites this paper
• Interleukins (Cytokines) as Biomarkers in Colorectal Cancer: Progression, Detection, and Monitoring

  2023cites this paper
• Plant extract from Caesalpinia spinosa inhibits cancer-associated fibroblast-like cells generation and function in a tumor microenvironment model

  2023influential citation
• Chemotherapy-induced PDL-1 expression in cancer-associated fibroblasts promotes chemoresistance in NSCLC.

  2023cites this paper
• Reshaping the Pancreatic Cancer Microenvironment at Different Stages with Chemotherapy

  2023cites this paper
• Fibroblasts in cancer: Unity in heterogeneity.

  2023cites this paper
• Cancer-associated fibroblasts refine the classifications of gastric cancer with distinct prognosis and tumor microenvironment characteristics

  2023cites this paper
• Are interleukin 17 and interleukin 23 inhibitors associated with malignancies?—Insights from an international population‐based study

  2023cites this paper
• Oral squamous cell carcinoma-derived EVs promote tumor progression by regulating inflammatory cytokines and the IL-17A-induced signaling pathway.

  2023cites this paper
• Heterotypic signaling of cancer-associated fibroblasts in shaping the cancer cell drug resistance

  2023cites this paper
• Metastatic colorectal adenocarcinoma tumor purity assessment from whole exome sequencing data

  2023cites this paper
• Ecological niches for colorectal cancer stem cell survival and thrival

  2023cites this paper
• Role of cancer-associated fibroblasts in colorectal cancer and their potential as therapeutic targets.

  2023cites this paper
• The origins, roles and therapies of cancer associated fibroblast in liver cancer

  2023cites this paper
• A comprehensive review on RNA interference-mediated targeting of interleukins and its potential therapeutic implications in colon cancer

  2022cites this paper
• Tumor microenvironment enriches the stemness features: the architectural event of therapy resistance and metastasis

  2022cites this paper
• Effects of metabolic cancer therapy on tumor microenvironment

  2022cites this paper
• Exosomal microRNAs mediating crosstalk between cancer cells and cancer-associated fibroblasts in the tumor microenvironment.

  2022cites this paper
• The extracellular matrix alteration, implication in modulation of drug resistance mechanism: friends or foes?

  2022cites this paper
• IL-17A promotes Helicobacter pylori-induced gastric carcinogenesis via interactions with IL-17RC

  2022cites this paper
• Intra‑tumor heterogeneity of cancer stem cell‑related genes and their potential regulatory microRNAs in metastasizing colorectal carcinoma.

  2022cites this paper
• Bioinformatics Analysis of RNA-seq Data Reveals Genes Related to Cancer Stem Cells in Colorectal Cancerogenesis

  2022cites this paper
• Defining the molecular landscape of cancer-associated stroma in cutaneous squamous cell carcinoma.

  2022cites this paper
• Extracellular Vesicles and Resistance to Anticancer Drugs: A Tumor Skeleton Key for Unhinging Chemotherapies

  2022cites this paper
• Helicobacter pylori actively suppresses innate immune nucleic acid receptors

  2022cites this paper
• Drug Resistance in Colorectal Cancer: From Mechanism to Clinic

  2022cites this paper
• Comparison of [68 Ga]Ga-DOTA-FAPI-04 PET/CT and [18F]FDG PET/CT in colorectal cancer

  2022cites this paper
• Targeting Tumour-Associated Fibroblasts in Cancers

  2022cites this paper
• Interplay Between Chemotherapy-Activated Cancer Associated Fibroblasts and Cancer Initiating Cells Expressing CD44v6 Promotes Colon Cancer Resistance

  2022cites this paper
• Cytokine Interaction With Cancer-Associated Fibroblasts in Esophageal Cancer

  2022cites this paper
• Reprogramming the tumor microenvironment by genome editing for precision cancer therapy

  2022cites this paper
• Cancer-associated fibroblasts and resistance to anticancer therapies: status, mechanisms, and countermeasures

  2022cites this paper
• Therapy resistance: opportunities created by adaptive responses to targeted therapies in cancer

  2022cites this paper
• Bête Noire of Chemotherapy and Targeted Therapy: CAF-Mediated Resistance

  2022cites this paper
• Drug resistance in cancer therapy: the Pandora's Box of cancer stem cells

  2022cites this paper
• Cancer-associated Fibroblasts: Origin, Function, Imaging, and Therapeutic Targeting.

  2022cites this paper